215 related articles for article (PubMed ID: 28256614)
1. MART-10 represses cholangiocarcinoma cell growth and high vitamin D receptor expression indicates better prognosis for cholangiocarcinoma.
Chiang KC; Yeh TS; Huang CC; Chang YC; Juang HH; Cheng CT; Pang JS; Hsu JT; Takano M; Chen TC; Kittaka A; Hsiao M; Yeh CN
Sci Rep; 2017 Mar; 7():43773. PubMed ID: 28256614
[TBL] [Abstract][Full Text] [Related]
2. MART-10, a novel vitamin D analog, inhibits head and neck squamous carcinoma cells growth through cell cycle arrest at G0/G1 with upregulation of p21 and p27 and downregulation of telomerase.
Chiang KC; Yeh CN; Hsu JT; Chen LW; Kuo SF; Sun CC; Huang CC; Pang JH; Flanagan JN; Takano M; Kittaka A; Juang HH; Yang SW; Chen TC
J Steroid Biochem Mol Biol; 2013 Nov; 138():427-34. PubMed ID: 24044969
[TBL] [Abstract][Full Text] [Related]
3. 25(OH)D Is Effective to Repress Human Cholangiocarcinoma Cell Growth through the Conversion of 25(OH)D to 1α,25(OH)₂D₃.
Chiang KC; Yeh CN; Huang CC; Yeh TS; S Pang JH; Hsu JT; Chen LW; Kuo SF; Kittaka A; Chen TC; Juang HH
Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27529229
[TBL] [Abstract][Full Text] [Related]
4. 1α,25(OH)2D3 Analog, MART-10, Inhibits Neuroendocrine Tumor Cell Growth Through Induction of G0/G1 Cell-cycle Arrest and Apoptosis.
Chiang KC; Yeh CN; Pang JH; Hsu JT; Yeh TS; Chen LW; Kuo SF; Hsieh PJ; Pan YC; Takano M; Chen TC; Feng TH; Kittaka A; Juang HH
Anticancer Res; 2016 Jul; 36(7):3307-13. PubMed ID: 27354587
[TBL] [Abstract][Full Text] [Related]
5. MART-10, the new brand of 1α,25(OH)2D3 analog, is a potent anti-angiogenic agent in vivo and in vitro.
Chiang KC; Sun CC; Chen MH; Huang CY; Hsu JT; Yeh TS; Chen LW; Kuo SF; Juang HH; Takano M; Kittaka A; Chen TC; Yeh CN; Pang JH
J Steroid Biochem Mol Biol; 2016 Jan; 155(Pt A):26-34. PubMed ID: 26385607
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of vitamin D receptor indicates a good prognosis for cholangiocarcinoma: implications for therapeutics.
Seubwai W; Wongkham C; Puapairoj A; Khuntikeo N; Wongkham S
Cancer; 2007 Jun; 109(12):2497-505. PubMed ID: 17487855
[TBL] [Abstract][Full Text] [Related]
7. MART-10, a less calcemic vitamin D analog, is more potent than 1α,25-dihydroxyvitamin D3 in inhibiting the metastatic potential of MCF-7 breast cancer cells in vitro.
Chiang KC; Chen SC; Yeh CN; Pang JH; Shen SC; Hsu JT; Liu YY; Chen LW; Kuo SF; Takano M; Kittaka A; Sun CC; Juang HH; Chen TC
J Steroid Biochem Mol Biol; 2014 Jan; 139():54-60. PubMed ID: 24125734
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the potential therapeutic role of a new generation of vitamin D analog, MART-10, in human pancreatic cancer cells in vitro and in vivo.
Chiang KC; Yeh CN; Hsu JT; Yeh TS; Jan YY; Wu CT; Chen HY; Jwo SC; Takano M; Kittaka A; Juang HH; Chen TC
Cell Cycle; 2013 Apr; 12(8):1316-25. PubMed ID: 23549173
[TBL] [Abstract][Full Text] [Related]
9. MART-10, a newly synthesized vitamin D analog, represses metastatic potential of head and neck squamous carcinoma cells.
Yang SW; Tsai CY; Pan YC; Yeh CN; Pang JH; Takano M; Kittaka A; Juang HH; Chen TC; Chiang KC
Drug Des Devel Ther; 2016; 10():1995-2002. PubMed ID: 27382252
[TBL] [Abstract][Full Text] [Related]
10. MART-10, the vitamin D analog, is a potent drug to inhibit anaplastic thyroid cancer cell metastatic potential.
Chiang KC; Kuo SF; Chen CH; Ng S; Lin SF; Yeh CN; Chen LW; Takano M; Chen TC; Juang HH; Kittaka A; Lin JD; Pang JH
Cancer Lett; 2015 Dec; 369(1):76-85. PubMed ID: 26282787
[TBL] [Abstract][Full Text] [Related]
11. 22-oxa-1,25-dihydroxyvitamin D3 efficiently inhibits tumor growth in inoculated mice and primary histoculture of cholangiocarcinoma.
Seubwai W; Wongkham C; Puapairoj A; Okada S; Wongkham S
Cancer; 2010 Dec; 116(23):5535-43. PubMed ID: 20681031
[TBL] [Abstract][Full Text] [Related]
12. Cell cycle arrest and apoptosis induced by 1α,25(OH)2D3 and TX 527 in Kaposi sarcoma is VDR dependent.
González-Pardo V; Suares A; Verstuyf A; De Clercq P; Boland R; de Boland AR
J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt A():197-200. PubMed ID: 24316429
[TBL] [Abstract][Full Text] [Related]
13. MART-10, a 1α,25(OH)
Chiang KC; Yeh CN; Yeh TS; Juang HH; Chen LW; Kuo SF; Chen MH; Chen TC; Takano M; Kittaka A; Pang JS
Anticancer Res; 2018 Jul; 38(7):3879-3887. PubMed ID: 29970508
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of 19-nor-2alpha-(3-hydroxypropyl)-1alpha,25-dihydroxyvitamin D3 as a therapeutic agent for androgen-dependent prostate cancer.
Flanagan JN; Zheng S; Chiang KC; Kittaka A; Sakaki T; Nakabayashi S; Zhao X; Spanjaard RA; Persons KS; Mathieu JS; Holick MF; Chen TC
Anticancer Res; 2009 Sep; 29(9):3547-53. PubMed ID: 19667147
[TBL] [Abstract][Full Text] [Related]
15. 1α,25(OH)
Chiang KC; Yeh CN; Pang JS; Hsu JT; Yeh TS; Chen LW; Kuo SF; Takano M; Chen TC; Kittaka A; Hsieh PJ; Juang HH
Anticancer Res; 2017 Nov; 37(11):6215-6221. PubMed ID: 29061804
[TBL] [Abstract][Full Text] [Related]
16. 19-Nor-2α-(3-hydroxypropyl)-1α,25-dihydroxyvitamin D3 (MART-10) is a potent cell growth regulator with enhanced chemotherapeutic potency in liver cancer cells.
Chiang KC; Yeh CN; Chen HY; Lee JM; Juang HH; Chen MF; Takano M; Kittaka A; Chen TC
Steroids; 2011 Dec; 76(13):1513-9. PubMed ID: 21888924
[TBL] [Abstract][Full Text] [Related]
17. 1,25-Dihydroxyvitamin D
Li M; Li L; Zhang L; Hu W; Shen J; Xiao Z; Wu X; Chan FL; Cho CH
Life Sci; 2017 Jun; 179():88-97. PubMed ID: 28465245
[TBL] [Abstract][Full Text] [Related]
18. The Vitamin D Analog, MART-10, Attenuates Triple Negative Breast Cancer Cells Metastatic Potential.
Chiang KC; Yeh TS; Chen SC; Pang JH; Yeh CN; Hsu JT; Chen LW; Kuo SF; Takano M; Kittaka A; Chen TC; Sun CC; Juang HH
Int J Mol Sci; 2016 Apr; 17(4):. PubMed ID: 27110769
[TBL] [Abstract][Full Text] [Related]
19. TAZ regulates cell proliferation and sensitivity to vitamin D3 in intrahepatic cholangiocarcinoma.
Xiao H; Tong R; Yang B; Lv Z; Du C; Peng C; Ding C; Cheng S; Zhou L; Xie H; Wu J; Zheng S
Cancer Lett; 2016 Oct; 381(2):370-9. PubMed ID: 27554639
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial oxidative metabolism contributes to a cancer stem cell phenotype in cholangiocarcinoma.
Raggi C; Taddei ML; Sacco E; Navari N; Correnti M; Piombanti B; Pastore M; Campani C; Pranzini E; Iorio J; Lori G; Lottini T; Peano C; Cibella J; Lewinska M; Andersen JB; di Tommaso L; Viganò L; Di Maira G; Madiai S; Ramazzotti M; Orlandi I; Arcangeli A; Chiarugi P; Marra F
J Hepatol; 2021 Jun; 74(6):1373-1385. PubMed ID: 33484774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
